Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Lowers Price Target to $93
Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and lowers the price target from $101 to $93.
JP Morgan Maintains Neutral on GFL Environmental, Lowers Price Target to $46.75
JP Morgan analyst Tami Zakaria maintains GFL Environmental (NYSE:GFL) with a Neutral and lowers the price target from $54 to $46.75.
JP Morgan Maintains Neutral on GFL Environmental, Lowers Price Target to $46.75
JP Morgan analyst Tami Zakaria maintains GFL Environmental (NYSE:GFL) with a Neutral and lowers the price target from $54 to $46.75.
HC Wainwright & Co. Reiterates Buy on Coinbase Global, Maintains $425 Price Target
HC Wainwright & Co. analyst Mike Colonnese reiterates Coinbase Global (NASDAQ:COIN) with a Buy and maintains $425 price target.
Guggenheim Reiterates Buy on Summit Therapeutics, Maintains $40 Price Target
Guggenheim analyst Brad Canino reiterates Summit Therapeutics (NASDAQ:SMMT) with a Buy and maintains $40 price target.
Scotiabank Maintains Sector Outperform on Oracle, Raises Price Target to $360
Scotiabank analyst Patrick Colville maintains Oracle (NYSE:ORCL) with a Sector Outperform and raises the price target from $350 to $360.
JP Morgan Maintains Neutral on Herc Holdings, Raises Price Target to $140
JP Morgan analyst Tami Zakaria maintains Herc Holdings (NYSE:HRI) with a Neutral and raises the price target from $127 to $140.
CIBC Maintains Neutral on Royal Gold, Raises Price Target to $250
CIBC analyst Anita Soni maintains Royal Gold (NASDAQ:RGLD) with a Neutral and raises the price target from $225 to $250.
Barclays Maintains Equal-Weight on Lincoln National, Raises Price Target to $46
Barclays analyst Alex Scott maintains Lincoln National (NYSE:LNC) with a Equal-Weight and raises the price target from $42 to $46.
Needham Initiates Coverage On Red Cat Holdings with Buy Rating, Announces Price Target of $17
Needham analyst Austin Bohlig initiates coverage on Red Cat Holdings (NASDAQ:RCAT) with a Buy rating and announces Price Target of $17.